As part of the global Grifols family of companies, Biomat USA provides services and products to help you improve the health and well-being of humanity. Grifols specializes in the development of high quality plasma derived therapies to ensure a consistent supply of life-saving products.
Biomat USA is the principal provider of plasma to Grifols Group and one of the leading North American suppliers of plasma for fractionation.
Today Biomat USA and PlasmaCare have a network of FDA licensed plasmapheresis centers in selected areas of the United States. The plasma undergoes rigorous testing in our US facilities to guarantee its quality before being sent to the fractionation facilities for further testing and manufacture into plasma derived therapies.